Dr. Erat (MD/PhD) studied medicine and trained in molecular and biomedical research at University of Zurich and Harvard Medical School.

Subsequently she was invited to Harvard Medical School as a post-doctoral fellow and consultant. In parallel she also did a doctorate in health systems management and epidemiology at the Business Faculty of the University of Zurich and SwissTPH.

After finishing her scientific training she worked as a consultant for the pharma- and biotech- industry in Switzerland and also as an expert for the Federal Office of Public Health (BAG).

Before finishing her training in internal medicine and sports medicine, she attended an executive management program at Harvard Business School. Furthermore, she successfully graduated from the INSEAD International Directors Program in 2019.

She is currently a medical director at Klinik Hirslanden focusing on preventive and personalized medicine and sits on numerous advisory boards in Switzerland.

Lambert has spent 24 years working for leading international management consulting firms focused on performance improvement, business transformation and cost reduction.

(Alexander Proudfoot, MCGplc, Hitachi Consulting, Renoir Group) In these companies, he held senior executive positions as business process analyst, head of auditing and assessment, business development VP and country manager.

The experience accumulated during those years conducting performance assessments and driving change management projects for more than 200 clients belonging to the world’s leading multinational corporations, government organizations, as well as to large and medium sized private companies in all types of industries and services in 36 countries, has provided Lambert with a truly global vision.

This business vision was further enhanced by spending 3 years working for the Exigen Group, a San Francisco based, multinational information technology corporation operating in the field of digital platforms for the telecommunication and financial services industry as well as offshore BPO (Business Process Outsourcing).

Lambert applied his business analysis skills to bridge information technology with operational needs and constraints and perfected his understanding of how to make them work best in the client’s interest. In 2007 Lambert decided to apply his change management expertise to the Healthcare sector by creating Boost Consulting.

Boost was founded with a mission to implement process, systems, organizational and behavioral changes in healthcare delivery, in order to improve the patient pathway; its quality and performance, whilst achieving measurable operational and financial gains.

Lambert and his team had observed that most management consultancy firms greatly underestimated the extreme complexity of healthcare and that none where offering integrated and tailor-made solutions to simultaneously address the four (processes, systems, organization, behavior) pillars of a change management program.

This insight spurred Boost to truly focus on the patient, not just in words but in action, and develop a unique approach to concurrently implement process, systems, organizational and behavioral improvements in healthcare institutions around the world.

Boost has carried out 25 projects for major hospitals in four continents and all are references. Lambert continues to act as an advisor and analyst for management consulting firms and is an “ambassador” for several hospitals.

Lambert is multicultural: French citizen, attending English, American, French schools and universities in Africa, Europe and the USA. Trilingual in English, French and Italian. Holds a PhD in political science and international relations. Lives near Milan, Italy

Daniel Faggella is Head of Research at Emerj. Called upon by the United Nations, World Bank, INTERPOL, and leading enterprises, Daniel is a globally sought-after expert on the competitive strategy implications of AI for business and government leaders.

Lars is the Chief Technology Officer and co-founder of Corti and has previously worked with companies like Apple and Issuu. He holds a PhD from the Technical University of Denmark with an extensive research and publication history within semi-supervised and unsupervised machine learning. He was nominated PhD of the year by the department of applied mathematics and computer science.

Dr. Eyal Zimlichman is an internal medicine physician, a health care executive and a researcher focused on assessing and improving health care quality and value, patient engagement and patient safety.

Dr. Zimlichman is currently Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center, Israel's largest hospital.

Prior to this Dr. Zimlichman has held the position of Lead Researcher at Partners Health Care Clinical Affairs Department in Boston where he was involved in the efforts to bring about a strategic care redesign initiative.

Dr. Zimlichman holds an appointment at Brigham and Women’s Hospital and Harvard Medical School affiliated Center for Patient Safety Research and Practice, where he is conducting research on implementing technology to improve health care quality and patient safety.

Dr. Zimlichman served as an advisor to the Office of the National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services and is a founding member of the International Academy of Quality and Safety in Health Care.

In his capacity as Chief Innovation Officer at Sheba Medical Center, Dr. Zimlichman conceptualized and launched a groundbreaking collaborative strategy called ARC which aims to accelerate innovations that will redesign healthcare on a global level.

Dr. Zimlichman is a graduate of the Harvard School of Public Health Executive Health Care Management Master of Science program and has earned his MD at the Technion Israel Institute of Technology in Haifa, Israel.

Dr. Alexander Wong is the Canada Research Chair in Artificial Intelligence and Medical Imaging at the University of Waterloo. Dr. Wong is a leading expert in artificial intelligence (particularly deep learning) and computational imaging (particularly in skin cancer, prostate cancer, and lung cancer imaging, cardiovascular imaging, and microscopy) and has published over 550 papers in leading journals and conferences, as well as holds 30 patents and patent applications in these areas. Dr. Wong has received numerous research awards at conferences and organizations such as NIPS, CRV, CVIS, Society of Information Display, Ministry of Research and Innovation, and the Imaging Network of Ontario.

In the area of artificial intelligence, Dr. Wong's focus is on operational deep learning (co-inventor/inventor of Generative Synthesis, evolutionary deep intelligence, Deep Bayesian Residual Transform, Discovery Radiomics, and random deep intelligence). In the area of computational imaging, Dr. Wong's focus is on integrative computational imaging systems for biomedical imaging (inventor/co-inventor of Correlated Diffusion Imaging, Compensated Magnetic Resonance Imaging, Spectral Light-field Fusion Micro-tomography, Coded Hemodynamic Imaging, High-throughput Computational Slits, and Spectral Demultiplexing Imaging).

Dr. Wong is also the co-founder of DarwinAI and Elucid Labs, and a Member of the Royal Society of Canada.

Specialties: Artificial intelligence, Machine learning, Deep learning, Computational imaging, Biomedical imaging and analysis, Computer vision.

Jefferson Fernandes is a Neurologist experienced in health management, education and research and digital health innovation, including telemedicine. He is the CEO of SPECIS - a Health Consulting Firm, Partner of SYTE Institute, Hamburg, Germany.

Dr Fernandes is Vice President of the Brazilian Association of Telemedicine and Telehealth, Coordinator of the Telemedicine Education Program of the Paulista Medical Association - SP (APM), and President of the Board of Curators, Global Summit Telemedicine & Digital Health, an international conference organized by APM. He is also Professor and Academic Coordinator of MBA courses at the Fundação Getulio Vargas - RJ, and IBCMED – SP.

Dr Jefferson was the founder and Director-General of the Higher School of Health Education and Sciences of the Hospital Alemão Oswaldo Cruz (HAOC), São Paulo, Brazil. He was also the Superintendent of Education, Sciences and Innovation of HAOC and Coordinated its Telemedicine and Telehealth Center.

He was the founder Director of the Institute of Education and Research of the Hospital Moinhos de Vento, Porto Alegre, RS, and also held a position of Full Professor (Neurology) at the School of Medicine of the Pontifical Catholic University of Rio Grande do Sul (PUCRS).

Dr Fernandes worked as a consultant for the World Health Organization (Geneva), for the World Bank (Washington), for the Brazilian Ministry of Health (Brasília) and for the Health Secretary of the Rio Grande do Sul State.

Dr Jefferson graduated in Medicine at the Federal University of Rio Grande do Sul (UFRGS), specialized in Neurosurgery and later in Neurology at the Institute of Neurology, University of London, England. Dr Fernandes has an MSc in Neuroanatomy and a Doctoral degree in Clinical Medicine, both at UFRGS. He has also done a postgraduate course in Hospital Administration and Health Business (IAHCS/PUCRS) and an MBA focused on Strategic Management and Information Technology (FGV).

Dr Fernandes has published in several scientific journals, chapters in medical books and articles in magazines for the lay public on neurology and several subjects, including telehealth and digital health innovation. He is a member of the American Telemedicine Association, of the International Society for Telemedicine and eHealth and of the Brazilian Academy of Neurology.

After 6 years of clinical practice in surgery, she has worked for the first Swiss telemedicine company and for the health department of Basel.

Beside these professional experiences she has achieved training in project management and a master in public health at the University of Geneva.

Ulrich Mühlner is a senior healthcare executive with 20 years of industry experience.

In 2016, he became an active startup investor and entrepreneur to enable life-changing healthcare innovations by joining forces with scientists, innovators, and entrepreneurs, and - together - translating groundbreaking ideas, discoveries, and inventions into services and products that make a real difference to people’s lives.

Dr Mühlner is particularly passionate about transforming the healthcare industry towards personalized and value-based healthcare through Digital Health solutions, in particular in the areas of Connected Care, Patient-Generated Health Data (PGHD) / Real World Evidence, and Artificial Intelligence / Deep Learning.

To fulfill this mission, Ulrich Mühlner co-founded docdok.health to develop docdok, a GDPR and HIPAA compliant cloud based solution connecting healthcare providers with their patients in the clinical and study ecosystems, 24/7, on all devices enabling to capture objective real world data (RWD) in addition to subjective patient reported outcomes (PROs) while significantly benefiting both patients and doctors.

He also serves globally as board member and advisor to biopharma and digital health / health tech companies (e.g., E-Medicus, Insilico Medicine, Medicinisto), as well as international organizations and leading academic institutions.

Ulrich Mühlner is a frequent speaker and panelist at international biopharma, medtech, and health tech / digital health conferences.

Previously, Dr Mühlner worked at Novartis and Boston Consulting Group (BCG).

At Novartis he served as Director and Head Global Corporate Strategy, Global Head Digital Health / Healthtech Partnerships.

In these roles, he was responsible for the multi-billion dollar portfolio transformation strategy and spearheaded globally the digital health activities across Novartis leading to major digital health partnerships (Google/Verily, IBM, Proteus) with the aim to better serve patients while increasing the value of the Novartis portfolio through ‘beyond-the-drug’ realworld outcomes solutions.

In total, Dr Mühlner successfully executed partnership deals with a volume of $350mn.

Dr Mühlner studied Biochemistry in Hannover and Munich, and earned a PhD degree in Biochemistry and Molecular Biology based on his research on molecular mechanisms of cancer development at the Research Institute of Molecular Pathology (I.M.P.) in Vienna.

Serial entrepreneur, Business/Technology leader with 3 meaningful exits:

Founded NetWiz, Merge with BATM (went to IPO in London) became later BATM/Telco systems (served as BATM/Telco CTO),

2 M&A: Founded WiNetworks - sold to Siemens and founded Spectrum (Own DBD GmbH) - sold to Deutsche Telekom

Ofer responsible for the development and launch of numerous products , and few breakthrough technology multidisciplinary projects and product .

Ofer served in one of the elite technology unit in the Israeli army and holds BSc from the Technion in Haifa Israel

Oxitone background:

Oxitone developed an end to end solution for Digital continuous care for patients at home.

We developed a wrist worn pulse oximeter ( without the bulky fingertip probe) that measure accurately 24/7 every second:

• SpO2 (Oxygen blood saturation)
• Pulse rate (heart rate)
• Heart Rate Variation (HRV)
• Activity/ steps ( accelerometer and Gyro)
• Skin temperature
• sleep pattern (coming soon)
• Fall detection (coming soon)

We can detect changes and trends and send automatic alarm messages when something go wrong.

I have been bringing ideas to life for more than 25 years in varying roles such as marketing, project management, and business development. With a focus on I.T., I specialize in helping companies develop products and bring them to market using proven marketing and business development strategies.

I have local and global business development experience, and bring depth to any project that I work on.

I am passionate about bringing together new ideas, high tech, and entrepreneurship. This has led me to teach "Global Innovation Ecosystems" at universities, where we explore how high-tech can breed new ideas in today's world and how it can be marketed globally. It has also led to me create, and head as President, the non-profit "High-Tech Connect Suisse" association, which encourages high-tech business development. I have organized 150+ high-tech business events in Switzerland and organized 15+ trips to Silicon Valley.

If you are interested in what I do and wish to connect with me for business or other opportunities, let's connect.